+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioprosthetics Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Bioprosthetics Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Bioprosthetics Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6083827
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioprosthetics Market grew from USD 7.14 billion in 2024 to USD 8.56 billion in 2025. It is expected to continue growing at a CAGR of 19.67%, reaching USD 20.98 billion by 2030.

The bioprosthetics sector stands at the convergence of advanced materials science, precision engineering and personalized medicine. As global populations age and chronic cardiovascular, orthopedic and wound care conditions rise, demand for biologically compatible implants and regenerative solutions has accelerated. Innovations in scaffold design, decellularization techniques and minimally invasive delivery systems are transforming patient outcomes and expanding indications. Simultaneously, regulatory bodies worldwide are streamlining approval pathways for breakthrough devices, while payers increasingly recognize the long-term cost savings of reduced reinterventions and faster recoveries. In this dynamic environment, stakeholders must navigate complex supply chains, evolving reimbursement models and intensified competition. The market’s trajectory hinges on strategic investments in research and development, resilient manufacturing capabilities and targeted collaborations among medtech companies, academic institutions and healthcare providers. Taking these factors into account, this executive summary outlines the key forces reshaping the landscape, assesses the impact of recent U.S. policy changes, offers deep segmentation and regional analyses, highlights leading competitors and concludes with actionable recommendations to drive sustainable growth.

Transformative Shifts Shaping the Bioprosthetics Landscape

Rapid technological breakthroughs are redefining how bioprosthetic devices are conceived, tested and deployed in clinical practice. Three-dimensional bioprinting now enables patient-specific heart valves and vascular grafts with microarchitectural precision, while next-generation nanomaterials enhance scaffold bioactivity and controlled drug delivery. Regenerative tissue engineering has progressed from proof of concept to commercial reality, with cellular seeding and scaffold-based constructs demonstrating robust in vivo integration. Concurrently, digital health platforms and remote-monitoring systems support post-implant surveillance, improving patient adherence and clinical decision-making. On the regulatory front, harmonization initiatives are reducing duplication of preclinical testing, accelerating time to market without compromising safety. Payers are increasingly rewarding value-based care models, incentivizing suppliers to demonstrate long-term efficacy and cost efficiency. Geopolitical shifts, including reshoring mandates and supply-chain diversification, are reshaping sourcing strategies for raw materials and component manufacturing. Together, these transformative shifts create new opportunities for market entrants and incumbents alike, demanding agility and a deep understanding of evolving stakeholder expectations.

Assessing the 2025 Tariff Implications on U.S. Bioprosthetics

As of 2025, cumulative U.S. tariffs on imported bioprosthetic components have introduced new cost pressures across the value chain. Raw materials sourced from bovine and porcine tissues, as well as advanced polymers manufactured overseas, now carry increased duties that inflate landed costs and compress manufacturer margins. Device producers have responded by evaluating nearshoring options and accelerating partnerships with domestic tissue banks and polymer developers. Although some cost increases are passed on to healthcare providers, payers are scrutinizing price escalations and may restrict coverage for high-cost implants without demonstrable outcome advantages. In parallel, import duties have spurred investment in automated processing lines and quality management systems to offset higher input costs through productivity gains. Despite short-term headwinds, these measures are fostering greater supply chain resilience and encouraging innovation in material sourcing, including exploration of synthetic biomaterials and decellularized allografts produced domestically. The net effect is a more vertically integrated ecosystem, where manufacturers balance tariff impacts with efficiency initiatives and strategic supplier relationships.

Strategic Segmentation Insights Across Products, Materials, Applications, End Users, Technologies, and Age Groups

Segmenting the bioprosthetics market reveals nuanced growth drivers and unmet needs across multiple dimensions. By product type, the landscape spans heart valves tailored for minimally invasive delivery, surgical and transcatheter approaches, soft tissue patches that include both hemostatic and regenerative variants, stents classified as bare-metal or drug-eluting devices, and vascular grafts designed for endovascular interventions as well as hemodialysis access. Material type segmentation demonstrates a diverse portfolio ranging from bovine pericardium and vein tissues to human cadaver allograft valves and patches, extending to polymeric materials such as electrospun and hybrid polymers, and porcine grafts applied to xenograft organ replacement and heart valve manufacturing. Application segmentation encompasses cardiovascular procedures including heart surgery and pulmonary artery repair, orthopedic interventions like bone replacement and cartilage repair, alongside wound care solutions for chronic wounds and traumatic injury. End user segmentation addresses ambulatory surgical centers comprising multi-specialty and single-specialty facilities, as well as hospitals spanning specialty, private and public institutions. Technology segmentation highlights 3D bioprinting via extrusion-based and laser-based methods, nanotechnology innovations in nano-therapies, nanomaterials and nanosensors, and tissue engineering techniques such as cellular seeding and scaffold-based constructs. Finally, age group segmentation differentiates adult elective surgeries and sports medicine applications, geriatric age-related degeneration and arthritis management, and pediatric solutions for congenital heart conditions and growth-oriented medical devices. Together, these segmentation insights guide product development, clinical strategy and commercialization efforts across the bioprosthetics ecosystem.

Regional Perspectives: Americas, EMEA, and Asia-Pacific Dynamics

Regional dynamics shape both demand patterns and competitive positioning within the bioprosthetics market. In the Americas, the United States leads with advanced reimbursement frameworks and high procedure volumes, while Canada and Latin American nations pursue cost-effective regenerative solutions amid constrained healthcare budgets. Across Europe, Middle East and Africa, mature markets in Western Europe emphasize minimally invasive and transcatheter innovations, whereas Eastern European and Middle Eastern regions prioritize foundational cardiovascular and wound care therapies. Africa remains an emerging frontier with significant unmet need and growing interest in low-cost, off-the-shelf bioprosthetic patches and grafts. The Asia-Pacific region exhibits a dual trajectory: developed markets such as Japan, Australia and South Korea drive adoption of next-generation scaffolds and nanotechnology-enhanced devices, while China, India and Southeast Asian countries accelerate capacity building in domestic manufacturing and regulatory alignment to meet vast patient populations. Local partnerships, tailored pricing models and region-specific clinical data generation have become critical success factors for market entrants, underscoring the importance of a differentiated go-to-market strategy aligned with each region’s healthcare infrastructure, regulatory requirements and payer dynamics.

Competitive Benchmarking: Leading Players in the Bioprosthetics Arena

Competition in the bioprosthetics arena is intensifying as firms leverage proprietary technologies, strategic alliances and geographic expansion to capture market share. Anteris Technologies Ltd. and Aortech International PLC are pioneering advanced tissue scaffolds with enhanced durability. Boston Scientific Corporation and Braile Biomedica, Inc. continue to strengthen their portfolios in transcatheter and minimally invasive heart valves, while Corcym UK Limited and Edwards Lifesciences Corporation maintain leadership roles across surgical and transcatheter valve systems. Foldax is advancing bioengineered vascular grafts, complemented by Getinge AB’s integrated cardiac surgery platforms. Hancock Jaffe Laboratories, Inc. and Humacyte, Inc. focus on regenerative patches and off-the-shelf vascular conduits, while JenaValve Technology GmbH and Labcor Laboratorios Ltd. innovate in next-generation transcatheter solutions. LeMaitre Vascular Inc. and Life Cell Corporation lead in soft tissue repair, supported by LifeNet Health’s allograft distribution network and LivaNova PLC’s hybrid polymer developments. Medical Devices Business Services, Inc. and Medtronic PLC enhance device integration through digital health capabilities, and Organogenesis, Inc. alongside Sorin Group drive wound care and cardiac repair innovations. Regional specialists such as Suzhou Jiecheng Medical Technology Co., Ltd and Ziacom Medical bolster manufacturing capacity in key Asia-Pacific markets. This competitive tapestry underscores the need for differentiation through clinical evidence, supply chain resilience and strategic partnerships.

Actionable Recommendations for Industry Leaders in Bioprosthetics

Industry leaders should prioritize six strategic actions to capitalize on evolving opportunities. First, invest in advanced manufacturing platforms and automation to mitigate tariff impacts and accelerate time to market. Second, diversify supply chains by forging partnerships with domestic tissue banks and polymer developers, ensuring raw material availability and quality control. Third, deepen R&D collaborations between device manufacturers, academic centers and contract research organizations to co-develop next-generation scaffolds and nanomaterial-enabled constructs. Fourth, differentiate portfolios through value-based clinical evidence, leveraging real-world data and health economics outcomes research to secure favorable reimbursement. Fifth, adopt digital health and remote monitoring solutions to enhance post-implant follow-up, patient engagement and predictive maintenance of bioprosthetic devices. Finally, tailor go-to-market models by region and end user, aligning product claims, pricing structures and regulatory strategies with local healthcare ecosystems. By executing these integrated recommendations, companies can strengthen competitive moats, optimize operational efficiency and deliver superior patient outcomes in the rapidly evolving bioprosthetics market.

Conclusion: Harnessing Innovation for Future Growth

The bioprosthetics market is poised for sustained growth, driven by converging technological breakthroughs, shifting payer expectations and rising global demand for minimally invasive and regenerative therapies. Navigating emerging challenges-such as evolving tariff regimes, complex regulatory landscapes and increasing competition-requires an agile, evidence-based approach to product development and market access. The insights presented here highlight the importance of comprehensive segmentation, regional customization and robust competitive benchmarking. Moving forward, organizations that align investments in advanced manufacturing, supply chain resilience and innovative partnerships will secure leadership positions. Simultaneously, demonstrating real-world clinical and economic value will prove essential to accessing reimbursement and driving adoption across diverse care settings. As stakeholders collaborate to translate scientific advances into scalable solutions, the potential to improve patient outcomes and unlock new revenue streams remains immense. Harnessing these opportunities will demand rigorous strategic planning, cross-functional alignment and a relentless focus on delivering superior quality and performance in every bioprosthetic offering.

Market Segmentation & Coverage

This research report categorizes the Bioprosthetics Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Heart Valves
    • Future: Minimally Invasive
    • Surgical
    • Transcatheter
  • Soft Tissue Patches
    • Hemostatic Patches
    • Regenerative Patches
  • Stents
    • Bare-Metal
    • Drug-Eluting
  • Vascular Grafts
    • Endovascular
    • Hemodialysis Access
  • Bovine Tissue
    • Pericardium
    • Veins
  • Human Cadaver Tissue
    • Allograft Valves
    • Tissue Patches
  • Polymeric Material
    • Future: Electrospun Polymers
    • Hybrid Polymers
  • Porcine Tissue
    • Future: Xenografts For Organ Replacement
    • Heart Valves
  • Cardiovascular
    • Heart Surgery
    • Pulmonary Artery Repair
  • Orthopedic
    • Bone Replacement
    • Cartilage Repair
  • Wound Care
    • Chronic Wounds
    • Traumatic Injury
  • Ambulatory Surgical Centers
    • Multi-Specialty Centers
    • Single-Specialty Centers
  • Hospitals
    • Future: Specialty Hospitals
    • Private Hospitals
    • Public Hospitals
  • 3D Bioprinting
    • Extrusion-Based
    • Laser-Based
  • Nanotechnology
    • Future: Nano-Therapies
    • Nanomaterials
    • Nanosensors
  • Tissue Engineering
    • Cellular Seeding
    • Scaffold-Based
  • Adult
    • Elective Surgeries
    • Sports Medicine
  • Geriatric
    • Age-Related Degeneration
    • Arthritis Management
  • Pediatric
    • Congenital Heart Conditions
    • Growth-Oriented Devices

This research report categorizes the Bioprosthetics Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Bioprosthetics Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Anteris Technologies Ltd.
  • Aortech International PLC
  • Boston Scientific Corporation
  • Braile Biomedica, Inc.
  • Corcym UK Limited
  • Edwards Lifesciences Corporation
  • Foldax
  • Getinge AB
  • Hancock Jaffe Laboratories, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular Inc.
  • Life Cell Corporation
  • LifeNet Health
  • LivaNova, PLC
  • Medical Devices Business Services, Inc.
  • Medtronic PLC
  • Organogenesis, Inc.
  • Sorin Group
  • Suzhou Jiecheng Medical Technology Co., Ltd
  • Ziacom Medical

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioprosthetics Market, by Product Type
8.1. Introduction
8.2. Heart Valves
8.2.1. Future: Minimally Invasive
8.2.2. Surgical
8.2.3. Transcatheter
8.3. Soft Tissue Patches
8.3.1. Hemostatic Patches
8.3.2. Regenerative Patches
8.4. Stents
8.4.1. Bare-Metal
8.4.2. Drug-Eluting
8.5. Vascular Grafts
8.5.1. Endovascular
8.5.2. Hemodialysis Access
9. Bioprosthetics Market, by Material Type
9.1. Introduction
9.2. Bovine Tissue
9.2.1. Pericardium
9.2.2. Veins
9.3. Human Cadaver Tissue
9.3.1. Allograft Valves
9.3.2. Tissue Patches
9.4. Polymeric Material
9.4.1. Future: Electrospun Polymers
9.4.2. Hybrid Polymers
9.5. Porcine Tissue
9.5.1. Future: Xenografts For Organ Replacement
9.5.2. Heart Valves
10. Bioprosthetics Market, by Application
10.1. Introduction
10.2. Cardiovascular
10.2.1. Heart Surgery
10.2.2. Pulmonary Artery Repair
10.3. Orthopedic
10.3.1. Bone Replacement
10.3.2. Cartilage Repair
10.4. Wound Care
10.4.1. Chronic Wounds
10.4.2. Traumatic Injury
11. Bioprosthetics Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.2.1. Multi-Specialty Centers
11.2.2. Single-Specialty Centers
11.3. Hospitals
11.3.1. Future: Specialty Hospitals
11.3.2. Private Hospitals
11.3.3. Public Hospitals
12. Bioprosthetics Market, by Technology
12.1. Introduction
12.2. 3D Bioprinting
12.2.1. Extrusion-Based
12.2.2. Laser-Based
12.3. Nanotechnology
12.3.1. Future: Nano-Therapies
12.3.2. Nanomaterials
12.3.3. Nanosensors
12.4. Tissue Engineering
12.4.1. Cellular Seeding
12.4.2. Scaffold-Based
13. Bioprosthetics Market, by Age Group
13.1. Introduction
13.2. Adult
13.2.1. Elective Surgeries
13.2.2. Sports Medicine
13.3. Geriatric
13.3.1. Age-Related Degeneration
13.3.2. Arthritis Management
13.4. Pediatric
13.4.1. Congenital Heart Conditions
13.4.2. Growth-Oriented Devices
14. Americas Bioprosthetics Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Bioprosthetics Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Bioprosthetics Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Anteris Technologies Ltd.
17.3.2. Aortech International PLC
17.3.3. Boston Scientific Corporation
17.3.4. Braile Biomedica, Inc.
17.3.5. Corcym UK Limited
17.3.6. Edwards Lifesciences Corporation
17.3.7. Foldax
17.3.8. Getinge AB
17.3.9. Hancock Jaffe Laboratories, Inc.
17.3.10. Humacyte, Inc.
17.3.11. JenaValve Technology GmbH
17.3.12. Labcor Laboratorios Ltd.
17.3.13. LeMaitre Vascular Inc.
17.3.14. Life Cell Corporation
17.3.15. LifeNet Health
17.3.16. LivaNova, PLC
17.3.17. Medical Devices Business Services, Inc.
17.3.18. Medtronic PLC
17.3.19. Organogenesis, Inc.
17.3.20. Sorin Group
17.3.21. Suzhou Jiecheng Medical Technology Co., Ltd
17.3.22. Ziacom Medical
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOPROSTHETICS MARKET MULTI-CURRENCY
FIGURE 2. BIOPROSTHETICS MARKET MULTI-LANGUAGE
FIGURE 3. BIOPROSTHETICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOPROSTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPROSTHETICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPROSTHETICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOPROSTHETICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOPROSTHETICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOPROSTHETICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPROSTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPROSTHETICS MARKET SIZE, BY FUTURE: MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPROSTHETICS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TRANSCATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPROSTHETICS MARKET SIZE, BY HEMOSTATIC PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGENERATIVE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPROSTHETICS MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPROSTHETICS MARKET SIZE, BY BARE-METAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPROSTHETICS MARKET SIZE, BY DRUG-ELUTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPROSTHETICS MARKET SIZE, BY ENDOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOPROSTHETICS MARKET SIZE, BY HEMODIALYSIS ACCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PERICARDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPROSTHETICS MARKET SIZE, BY VEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOPROSTHETICS MARKET SIZE, BY ALLOGRAFT VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TISSUE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOPROSTHETICS MARKET SIZE, BY FUTURE: ELECTROSPUN POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPROSTHETICS MARKET SIZE, BY HYBRID POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOPROSTHETICS MARKET SIZE, BY FUTURE: XENOGRAFTS FOR ORGAN REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPROSTHETICS MARKET SIZE, BY HEART SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PULMONARY ARTERY REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPROSTHETICS MARKET SIZE, BY BONE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOPROSTHETICS MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPROSTHETICS MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TRAUMATIC INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOPROSTHETICS MARKET SIZE, BY MULTI-SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOPROSTHETICS MARKET SIZE, BY SINGLE-SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOPROSTHETICS MARKET SIZE, BY FUTURE: SPECIALTY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOPROSTHETICS MARKET SIZE, BY EXTRUSION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOPROSTHETICS MARKET SIZE, BY LASER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIOPROSTHETICS MARKET SIZE, BY FUTURE: NANO-THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIOPROSTHETICS MARKET SIZE, BY NANOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIOPROSTHETICS MARKET SIZE, BY NANOSENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BIOPROSTHETICS MARKET SIZE, BY CELLULAR SEEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BIOPROSTHETICS MARKET SIZE, BY SCAFFOLD-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BIOPROSTHETICS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BIOPROSTHETICS MARKET SIZE, BY ELECTIVE SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BIOPROSTHETICS MARKET SIZE, BY SPORTS MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BIOPROSTHETICS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BIOPROSTHETICS MARKET SIZE, BY AGE-RELATED DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BIOPROSTHETICS MARKET SIZE, BY ARTHRITIS MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL BIOPROSTHETICS MARKET SIZE, BY CONGENITAL HEART CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL BIOPROSTHETICS MARKET SIZE, BY GROWTH-ORIENTED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS BIOPROSTHETICS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL BIOPROSTHETICS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 167. CANADA BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. CANADA BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 169. CANADA BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 170. CANADA BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 171. CANADA BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 172. CANADA BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 173. CANADA BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 174. CANADA BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 175. CANADA BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 176. CANADA BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 177. CANADA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. CANADA BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 179. CANADA BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 180. CANADA BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 181. CANADA BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. CANADA BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 183. CANADA BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 184. CANADA BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. CANADA BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 186. CANADA BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. CANADA BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 188. CANADA BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 189. CANADA BIOPROSTHETICS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 190. CANADA BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 191. CANADA BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 192. MEXICO BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. MEXICO BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 194. MEXICO BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 195. MEXICO BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 197. MEXICO BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 198. MEXICO BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 199. MEXICO BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 200. MEXICO BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 201. MEXICO BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 202. MEXICO BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. MEXICO BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 204. MEXICO BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 205. MEXICO BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 206. MEXICO BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. MEXICO BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 208. MEXICO BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. MEXICO BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. MEXICO BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 211. MEXICO BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. MEXICO BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 213. MEXICO BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 214. MEXICO BIOPROSTHETICS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 215. MEXICO BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 216. MEXICO BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 242. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 277. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 278. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 288. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 289. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 290. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 291. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 294. CHINA BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. CHINA BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 296. CHINA BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 297. CHINA BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 298. CHINA BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 299. CHINA BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 300. CHINA BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 301. CHINA BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 302. CHINA BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 303. CHINA BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 304. CHINA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. CHINA BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 306. CHINA BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 307. CHINA BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 308. CHINA BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. CHINA BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 310. CHINA BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 311. CHINA BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. CHINA BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 313. CHINA BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. CHINA BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 315. CHINA BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 316. CHINA BIOPROSTHETICS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 317. CHINA BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 318. CHINA BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 319. INDIA BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. INDIA BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 321. INDIA BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 322. INDIA BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 323. INDIA BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 324. INDIA BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 325. INDIA BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 326. INDIA BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 327. INDIA BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 328. INDIA BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 329. INDIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. INDIA BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 331. INDIA BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 332. INDIA BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 333. INDIA BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. INDIA BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 335. INDIA BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 336. INDIA BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 337. INDIA BIOPROSTHETICS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 338. INDIA BIOPROSTHETICS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 339. INDIA BIOPROSTHETICS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 340. INDIA BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 341. INDIA BIOPROSTHETICS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 342. INDIA BIOPROSTHETICS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 343. INDIA BIOPROSTHETICS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 344. INDONESIA BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. INDONESIA BIOPROSTHETICS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 346. INDONESIA BIOPROSTHETICS MARKET SIZE, BY SOFT TISSUE PATCHES, 2018-2030 (USD MILLION)
TABLE 347. INDONESIA BIOPROSTHETICS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 348. INDONESIA BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 349. INDONESIA BIOPROSTHETICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 350. INDONESIA BIOPROSTHETICS MARKET SIZE, BY BOVINE TISSUE, 2018-2030 (USD MILLION)
TABLE 351. INDONESIA BIOPROSTHETICS MARKET SIZE, BY HUMAN CADAVER TISSUE, 2018-2030 (USD MILLION)
TABLE 352. INDONESIA BIOPROSTHETICS MARKET SIZE, BY POLYMERIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 353. INDONESIA BIOPROSTHETICS MARKET SIZE, BY PORCINE TISSUE, 2018-2030 (USD MILLION)
TABLE 354. INDONESIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 355. INDONESIA BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA BIOPROSTHETICS MARKET SIZE, BY WOUND CARE, 2018-2030 (USD MILLION)
TABLE 358. INDONESIA BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 359. INDONESIA BIOPROSTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 360. INDONESIA BIOPROSTHETICS MARKET SIZE, BY HOSPITA

Companies Mentioned

  • Anteris Technologies Ltd.
  • Aortech International PLC
  • Boston Scientific Corporation
  • Braile Biomedica, Inc.
  • Corcym UK Limited
  • Edwards Lifesciences Corporation
  • Foldax
  • Getinge AB
  • Hancock Jaffe Laboratories, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular Inc.
  • Life Cell Corporation
  • LifeNet Health
  • LivaNova, PLC
  • Medical Devices Business Services, Inc.
  • Medtronic PLC
  • Organogenesis, Inc.
  • Sorin Group
  • Suzhou Jiecheng Medical Technology Co., Ltd
  • Ziacom Medical

Methodology

Loading
LOADING...

Related Topics

Related Reports

Bioprosthetics Market by Type, Application - Global Forecast 2025-2030 - Product Image

Bioprosthetics Market by Type, Application - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Bioprosthetics Market Size, Share & Trends Analysis Report by Product (Allograft, Xenograft), Application (Cardiovascular, Plastic Surgery & Wound Healing), and Region with Growth Forecasts, 2025-2030 - Product Image

Bioprosthetics Market Size, Share & Trends Analysis Report by Product (Allograft, Xenograft), Application (Cardiovascular, Plastic Surgery & Wound Healing), and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Bioprosthetics - Global Strategic Business Report - Product Image

Bioprosthetics - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Bioprosthetics Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Bioprosthetics Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 92 Pages
  • Global
From
Orthopedic Soft Tissue Repair Market Size, Share & Trends Analysis Report by Application (Rotator Cuff Repair, Epicondylitis), Injury Location (Knee, Shoulder), Region, and Segment Forecasts, 2024-2030 - Product Image

Orthopedic Soft Tissue Repair Market Size, Share & Trends Analysis Report by Application (Rotator Cuff Repair, Epicondylitis), Injury Location (Knee, Shoulder), Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From

About the Bioprosthetic Market

The bioprosthetic market within the context of orthopedic devices is a rapidly growing sector of the medical device industry. Bioprosthetics are artificial implants made from biological materials, such as collagen, that are designed to replace or repair damaged or diseased tissue. These implants are used in a variety of orthopedic procedures, including joint replacement, spinal fusion, and fracture repair. Bioprosthetics offer a number of advantages over traditional implants, including improved durability, flexibility, and biocompatibility. Bioprosthetics are becoming increasingly popular in the orthopedic device market due to their ability to provide a more natural feel and improved patient outcomes. As a result, many companies are investing in the development of new bioprosthetic products and technologies. Some of the leading companies in the bioprosthetic market include Zimmer Biomet, Stryker, Smith & Nephew, and Medtronic. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.